Sabra Healthcare REIT Inc [NASDAQ: SBRA] gained 3.47% on the last trading session, reaching $13.40 price per share at the time. The company report on February 1, 2024 at 4:05 PM that Sabra Health Care REIT, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call; Declares Common Dividend.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading.
A conference call with a simultaneous webcast to discuss the 2023 fourth quarter results will be held on Wednesday, February 28 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-596-4144. For participants outside the U.S., the dial-in number is 646-968-2525. The conference ID number is 1382596.
If compared to the average trading volume of 2.07M shares, SBRA reached a trading volume of 2941673 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Sabra Healthcare REIT Inc [SBRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SBRA shares is $15.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SBRA stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Deutsche Bank have made an estimate for Sabra Healthcare REIT Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 30, 2024.
The Average True Range (ATR) for Sabra Healthcare REIT Inc is set at 0.32, with the Price to Sales ratio for SBRA stock in the period of the last 12 months amounting to 4.87. The Price to Book ratio for the last quarter was 1.08, with the Price to Cash per share for the same quarter was set at 0.17. Price to Free Cash Flow for SBRA in the course of the last twelve months was 10.69.
Trading performance analysis for SBRA stock
Sabra Healthcare REIT Inc [SBRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.30. With this latest performance, SBRA shares dropped by -2.26% in over the last four-week period, additionally plugging by 8.35% over the last 6 months – not to mention a rise of 4.77% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SBRA stock in for the last two-week period is set at 47.10, with the RSI for the last a single of trading hit 50.89, and the three-weeks RSI is set at 45.95 for Sabra Healthcare REIT Inc [SBRA]. The present Moving Average for the last 50 days of trading for this stock 13.94, while it was recorded at 13.06 for the last single week of trading, and 13.01 for the last 200 days.
Sabra Healthcare REIT Inc [SBRA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Sabra Healthcare REIT Inc posted -0.37/share EPS, while the average EPS was predicted by analysts to be reported at 0.12/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -408.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SBRA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sabra Healthcare REIT Inc go to 7.30%.
An analysis of Institutional ownership at Sabra Healthcare REIT Inc [SBRA]
The top three institutional holders of SBRA stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in SBRA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in SBRA stock with ownership which is approximately 5.8325%.
